Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride · CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 · Tablet, Film Coated, Extended Release · Oral · Strategic Sourcing Services Llc
NDC 70677-1020-02 · 2 BLISTER PACK in 1 CARTON / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →
9 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.5776 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market · price up 3% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Kenvue Brands LLC | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurohealth LLC | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Consortium,llc | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ohm Laboratories Inc. | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rite Aid | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strategic Sourcing Services Llc | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Unichem Pharmaceuticals (USA), Inc. | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Aug 12, 2026 | Sep 2, 2026 |
| Walgreen Company | CETIRIZINE HYDROCHLORIDE 5 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Allergy relief-D — NDC 70677-1020-02," retrieved September 3, 2026, https://drugdashboards.com/drug/70677102002.
Free to cite with attribution — see how the data is put together.